YAB3 Antibody

Shipped with Ice Packs
In Stock

Description

TAB3 Antibody: Definition and Context

TAB3 (TAK1-binding protein 3) is an adapter protein that interacts with TAK1 (Transforming Growth Factor-β-Activated Kinase 1) to modulate immune and stress signaling pathways. Anti-TAB3 antibodies are tools used to study these pathways in research settings.

Key Characteristics of Anti-TAB3 Antibody (ab85655):

AttributeDetails
TypeRabbit Polyclonal
TargetHuman/Mouse TAB3 (aa 600–650)
ImmunogenSynthetic peptide within Human TAB3 aa 600–650
ApplicationsImmunoprecipitation (IP), Western Blot (WB)
Predicted Band Size79 kDa
ReactivityHuman, Mouse
CitationsUsed in studies on NF-κB signaling, miRNA regulation, and hepatocellular carcinoma .

Function and Mechanism of Action

Anti-TAB3 antibodies are used to study TAB3’s role in signaling cascades:

  • TAK1-TAB3 Complex: TAB3 binds to TAK1 via its NZF domain, recognizing Lys-63-linked polyubiquitin chains. This interaction facilitates autophosphorylation of TAK1, activating downstream pathways like NF-κB and JNK .

  • Role in Pathways:

    • Immune Response: Modulates TNFα-induced NF-κB activation.

    • Stress Response: Regulates cellular responses to stress signals.

    • Oncogenic Potential: Isoform 2 may act as an oncogenic factor in certain cancers .

3.1. Western Blot and Immunoprecipitation

  • Western Blot: Detects TAB3 in cell lysates (e.g., HeLa, NIH3T3). A band at ~79 kDa confirms specificity .

  • Immunoprecipitation: Validates protein-protein interactions (e.g., TAK1-TAB3 complexes) .

3.2. Key Studies

StudyFindings
miR-26b RegulationmiR-26b suppresses TAB3 expression, inhibiting NF-κB activity in hepatocellular carcinoma .
TNFα SignalingKnockdown of TAB3 reduces TNFα-induced phosphorylation of IκBα and p65, impairing NF-κB activation .
Oncogenic RoleTAB3 isoform 2 may contribute to cancer progression, though mechanisms remain unclear .

Broader Context: Antibody Therapeutics and YAbS Database

While TAB3 is not a therapeutic antibody, insights from YAbS (The Antibody Society’s database) highlight trends in antibody development:

  • YAbS Overview: Tracks over 2,900 investigational and approved antibodies, including formats (monospecific, bispecific, ADCs) and targets .

  • Clinical Trends:

    • Cancer Dominates: 66% of clinical-stage antibodies target oncology .

    • Molecular Innovation: Bispecific antibodies and ADCs show shorter development timelines compared to naked antibodies .

Limitations and Future Directions

  • Data Gaps: Early-stage antibody candidates may lack publicly disclosed details, limiting YAbS’s coverage .

  • TAB3 Relevance: Anti-TAB3 antibodies remain research tools; therapeutic applications are speculative.

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
YAB3 antibody; At4g00180 antibody; F6N15.22 antibody; Axial regulator YABBY 3 antibody
Target Names
YAB3
Uniprot No.

Target Background

Function
YAB3 is involved in abaxial cell fate determination during embryogenesis and organogenesis. It regulates the initiation of embryonic shoot apical meristem (SAM) development and contributes to the repression of KNOX genes (STM, KNAT1/BP, and KNAT2) to prevent the formation of ectopic meristems. YAB3 binds DNA, although it lacks sequence specificity.
Gene References Into Functions
YAB3's function is further elucidated by the following research: 1. YAB3 interacts with LUG and LUH to maintain leaf polarity and meristem activity in Arabidopsis. (PMID: 19837869) 2. Mutations in YABBY3 (YAB3) result in various developmental defects, including aberrant phyllotaxis. (PMID: 18469164)
Database Links

KEGG: ath:AT4G00180

STRING: 3702.AT4G00180.1

UniGene: At.11867

Protein Families
YABBY family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in abaxial regions of lateral aerial organ primordia leading to cotyledons, leaves, flower meristems, sepals, petals, stamen and carpels, but not in roots.

Q&A

What is YAB3 protein and why are antibodies against it important for plant research?

YAB3 (YABBY3) is a plant-specific transcription factor belonging to the YABBY family, characterized by a zinc finger domain and a YABBY domain. In Oryza sativa (rice), it is also known as OsYAB4 or OsYABBY3 . YAB3 plays crucial roles in determining the abaxial cell fate in lateral organs and establishing leaf polarity in plants.

Antibodies against YAB3 are important research tools that enable:

  • Protein localization studies to understand spatial distribution of YAB3 in different tissues

  • Chromatin immunoprecipitation (ChIP) experiments to identify DNA binding sites

  • Protein-protein interaction studies to elucidate YAB3's role in transcriptional complexes

  • Quantification of YAB3 expression levels in different developmental stages or under various conditions

These applications have significantly advanced our understanding of plant organ development and polarity establishment, making YAB3 antibodies indispensable tools for plant developmental biologists.

What expression systems are optimal for producing YAB3 protein for antibody generation?

The choice of expression system significantly impacts the quality and utility of YAB3 proteins for antibody production. Based on current evidence, several systems can be considered:

Yeast Expression System: This is a highly economical and efficient eukaryotic system for YAB3 expression. The yeast system produces proteins that maintain post-translational modifications similar to those in plants while offering higher protein yields than plant-based systems . The YAB3 protein expressed in yeast demonstrates good solubility and can maintain proper folding of the zinc finger domain.

E. coli Expression System: While not ideal for full-length YAB3 due to potential misfolding issues with the zinc finger domain, bacterial systems can be effective for expressing specific epitope regions or peptides of YAB3 for generating antibodies against targeted regions.

Mammalian Cell Expression: This system produces proteins very close to their natural conformation but has drawbacks including higher cost and lower expression levels compared to yeast systems .

For optimal YAB3 antibody generation, the recombinant protein should include amino acids 1-313 with a purification tag such as His-tag that can be used for purification while minimizing interference with the protein's native structure .

How can I validate the specificity of a YAB3 antibody?

Validating antibody specificity is critical for reliable research outcomes. For YAB3 antibodies, a multi-faceted validation approach is recommended:

  • Western Blot Analysis:

    • Compare wild-type plants with yab3 knockout/knockdown mutants

    • Expected molecular weight for Oryza sativa YAB3 is approximately 34 kDa

    • Test for cross-reactivity with other YABBY family proteins

  • Immunoprecipitation Followed by Mass Spectrometry:

    • Confirm that the immunoprecipitated protein is indeed YAB3

    • Identify potential cross-reacting proteins

  • Immunohistochemistry Controls:

    • Compare antibody staining patterns with known YAB3 expression patterns

    • Include negative controls (pre-immune serum, secondary antibody only)

    • Use known YAB3-expressing tissues (young leaf primordia, floral organs)

  • Peptide Competition Assay:

    • Pre-incubate antibody with excess purified YAB3 protein or immunizing peptide

    • Observe elimination of specific signal in subsequent applications

  • ELISA Titration:

    • Determine antibody sensitivity and optimal working concentration

    • Test against both recombinant YAB3 protein and plant tissue extracts

Documentation of these validation steps is essential for research reproducibility and reliability.

What are the recommended storage conditions for maintaining YAB3 antibody activity?

Proper storage of YAB3 antibodies is crucial for maintaining reactivity and specificity over time. Based on standard antibody handling protocols:

  • Long-term Storage:

    • Store antibody aliquots at -80°C for maximum stability

    • Avoid repeated freeze-thaw cycles (limit to <5)

    • Add stabilizing proteins like BSA (0.1-1%) if antibody concentration is low

  • Working Storage:

    • Keep at 4°C for up to 1 month with antimicrobial preservatives (0.02% sodium azide)

    • Monitor for signs of degradation (precipitates, loss of activity)

  • Formulation Considerations:

    • pH maintenance between 6.5-7.5 is optimal for IgG stability

    • Glycerol (25-50%) can be added for freezer storage to prevent freeze-thaw damage

  • Quality Control:

    • Periodically test stored antibodies against positive controls

    • Document antibody performance over time to establish reliable shelf-life

  • Shipping Considerations:

    • Ship on ice packs for short distances/durations

    • Use dry ice for long-distance shipping

    • Include temperature indicators for monitoring

Maintaining proper storage records and regular testing are essential practices that ensure antibody reliability throughout a research project.

How can computational modeling improve YAB3 antibody design and specificity?

Computational modeling offers powerful approaches for enhancing antibody design and characterization, particularly for challenging targets like plant-specific transcription factors. For YAB3 antibodies, computational approaches can provide several advantages:

Structural Modeling and Epitope Prediction:

  • Homology modeling can predict the 3D structure of YAB3 protein based on related proteins with known structures

  • Epitope mapping algorithms can identify surface-exposed, unique regions of YAB3 that would make ideal antibody targets

  • These regions can be specifically selected for generating peptide antigens, increasing antibody specificity

Antibody-Antigen Docking Simulations:

  • Computational docking can model potential interactions between antibody complementarity-determining regions (CDRs) and YAB3 epitopes

  • Molecular dynamics simulations can refine these models to account for flexibility of both antibody and antigen

  • These simulations help predict binding affinity and potential cross-reactivity

Validation Through Combined Computational-Experimental Approach:

  • Site-directed mutagenesis of predicted key binding residues can verify computational models

  • Saturation transfer difference NMR (STD-NMR) can experimentally define the contact surface between antibody and antigen

  • These experimental data can be used to select optimal models from thousands generated by automated docking

This integrated approach has been successfully applied to other antibody-antigen pairs and could significantly improve YAB3 antibody development by guiding the selection of highly specific epitopes and validating binding interactions before extensive experimental work.

What techniques can be used for epitope mapping of YAB3 antibodies?

Precise epitope mapping is essential for understanding antibody specificity and functionality. For YAB3 antibodies, several complementary techniques can be employed:

X-ray Crystallography and Cryo-EM:

  • Provides atomic-level resolution of antibody-antigen complexes

  • Challenging for YAB3 due to its flexible regions and potential glycosylation

  • May require truncated constructs focusing on stable domains

Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS):

  • Identifies epitopes based on changes in hydrogen/deuterium exchange rates upon antibody binding

  • Particularly useful for conformational epitopes

  • Requires specialized equipment but provides high-resolution mapping

Peptide Array Analysis:

  • Synthetic overlapping peptides covering the YAB3 sequence are tested for antibody binding

  • Identifies linear epitopes with precision

  • May miss conformational epitopes dependent on tertiary structure

Site-Directed Mutagenesis:

  • Systematic mutation of potential epitope residues followed by binding assays

  • Identifies key contact residues critical for antibody recognition

  • Can be guided by computational predictions to reduce experimental burden

Saturation Transfer Difference NMR (STD-NMR):

  • Non-destructive technique that identifies antigen residues in close proximity to antibody

  • Provides dynamic information about the binding interface

  • Requires significant amounts of purified materials

A combined approach utilizing computational predictions followed by experimental validation often yields the most comprehensive epitope characterization, enabling rational improvement of antibody specificity and affinity.

How can ChIP-seq experiments be optimized when using YAB3 antibodies?

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) with YAB3 antibodies presents unique challenges due to the nature of plant transcription factors. The following optimization strategies can enhance success:

Cross-linking Optimization:

  • Test multiple formaldehyde concentrations (0.5-3%) and incubation times (5-20 minutes)

  • Double cross-linking with disuccinimidyl glutarate (DSG) followed by formaldehyde can improve results for transcription factors with indirect DNA binding

  • Optimize based on YAB3's interaction with DNA (likely through its zinc finger domain)

Sonication Parameters:

  • Plant tissues often require more aggressive sonication due to cell wall components

  • Aim for chromatin fragments of 200-500 bp for optimal resolution

  • Verify fragmentation efficiency by gel electrophoresis before proceeding

Antibody Selection and Validation:

  • Rigorously validate antibody specificity using western blots and immunoprecipitation

  • Test multiple antibodies targeting different epitopes of YAB3

  • Consider using tagged versions of YAB3 with high-affinity antibodies to tags as an alternative

Control Experiments:

  • Include input controls, IgG controls, and ideally, tissue from yab3 mutants as negative controls

  • Include positive controls by testing enrichment at known YAB3 binding sites

Data Analysis Considerations:

  • Use peak calling algorithms optimized for transcription factors

  • Motif analysis to confirm enrichment of YAB3 binding motifs

  • Integration with transcriptomic data to correlate binding with gene expression changes

This methodological framework should be adjusted based on specific plant species and tissues, with careful documentation of all optimization steps to ensure reproducibility.

What approaches can address cross-reactivity issues when using YAB3 antibodies across plant species?

Cross-reactivity issues are common when applying antibodies developed against one plant species' proteins to another species. For YAB3 antibodies, several strategies can mitigate these challenges:

Sequence Homology Analysis:

  • Compare YAB3 protein sequences across target plant species

  • Identify conserved and divergent regions through multiple sequence alignment

  • Target antibody generation to highly conserved epitopes for cross-species applications

Epitope-Specific Antibody Development:

  • Design antibodies against species-conserved epitopes for broad applications

  • Alternatively, develop species-specific antibodies targeting unique regions

  • Combine computational modeling with experimental validation to identify optimal epitopes

Cross-Reactivity Testing Matrix:

  • Systematically test antibodies against protein extracts from multiple plant species

  • Use western blots, ELISA, and immunoprecipitation to quantify cross-reactivity

  • Document species-specific working dilutions and conditions

Recombinant Protein Controls:

  • Express recombinant YAB3 from each target species as positive controls

  • Use these controls to calibrate antibody performance across species

  • Consider species-specific post-translational modifications that may affect recognition

Pre-adsorption Techniques:

  • Pre-incubate antibodies with extracts from distant plant species to remove broadly cross-reactive antibodies

  • Enrich for species-specific recognition through affinity purification

Careful documentation of cross-reactivity profiles enables researchers to select appropriate antibodies and experimental conditions for their specific plant species of interest.

What are the latest innovations in using YAB3 antibodies for protein-protein interaction studies?

Recent methodological advances have expanded the utility of antibodies for studying protein-protein interactions (PPIs) of transcription factors like YAB3:

Proximity Labeling Techniques:

  • BioID or TurboID fusion with YAB3 combined with specific antibodies enables identification of proximal proteins in vivo

  • APEX2-based proximity labeling provides temporal resolution of dynamic interactions

  • These approaches capture transient interactions often missed by traditional co-immunoprecipitation

Single-Molecule Co-Immunoprecipitation:

  • Combines antibody-based purification with single-molecule detection

  • Enables quantification of interaction stoichiometry and dynamics

  • Particularly valuable for studying transcription factor complexes like those involving YAB3

Förster Resonance Energy Transfer (FRET)-based Approaches:

  • Antibody fragments labeled with fluorophores can detect protein interactions in live cells

  • Provides spatial and temporal information about YAB3 interactions

  • Useful for studying dynamic complex formation during developmental transitions

Mass Spectrometry Integration:

  • Antibody-purified complexes analyzed by quantitative mass spectrometry

  • Cross-linking mass spectrometry (XL-MS) can map interaction interfaces

  • Data integration with computational modeling enhances structural understanding of complexes

Microfluidic Antibody-Capture Techniques:

  • High-throughput analysis of protein interactions under various conditions

  • Enables screening of interaction partners across developmental stages or stress conditions

  • Reduces sample requirements, particularly valuable for limited plant tissue samples

These innovative approaches, when applied to YAB3 research, can reveal new insights into how this transcription factor functions within larger protein complexes to regulate gene expression during plant development.

How can I troubleshoot poor signal or high background when using YAB3 antibodies?

Troubleshooting antibody performance issues requires systematic investigation of multiple factors:

Poor Signal Issues and Solutions:

ProblemPotential CausesTroubleshooting Approaches
No signal or weak signalInsufficient antigenIncrease protein loading; optimize extraction buffers for nuclear proteins
Antibody degradationTest new antibody aliquot; check storage conditions
Inefficient transfer (western blot)Optimize transfer conditions for higher MW proteins
Epitope maskingTry different extraction buffers; consider antigen retrieval for IHC
Low antibody concentrationTitrate antibody to determine optimal concentration

High Background Issues and Solutions:

ProblemPotential CausesTroubleshooting Approaches
High backgroundNon-specific bindingIncrease blocking time/concentration; try different blocking agents
Secondary antibody issuesInclude secondary-only control; try different secondary antibody
Inadequate washingIncrease number/duration of washes; use detergent in wash buffer
Cross-reactivityPre-adsorb antibody with non-target proteins; affinity purify antibody
Autofluorescence (IF/IHC)Include untreated control; use specific quenching methods

Methodological Optimization:

  • For western blots: Test different membrane types (PVDF vs. nitrocellulose)

  • For immunoprecipitation: Adjust salt concentration in wash buffers

  • For immunohistochemistry: Optimize fixation methods and antigen retrieval protocols

  • For ChIP applications: Adjust cross-linking conditions and sonication parameters

Maintaining detailed records of troubleshooting experiments is essential for establishing optimal conditions for each application and tissue type.

How should I quantitatively assess the affinity and specificity of YAB3 antibodies?

Rigorous quantitative assessment of antibody properties is essential for reproducible research. For YAB3 antibodies, consider these methodologies:

Affinity Measurements:

  • Surface Plasmon Resonance (SPR): Provides precise kinetic measurements (kon, koff) and equilibrium dissociation constants (KD)

  • Bio-Layer Interferometry (BLI): Alternative to SPR with simpler setup requirements

  • Isothermal Titration Calorimetry (ITC): Provides thermodynamic parameters of binding

Specificity Assessments:

  • Competitive ELISA: Quantifies cross-reactivity with related YABBY family proteins

  • Western Blot Against Multiple Species: Determines cross-species reactivity profile

  • Immunoprecipitation-Mass Spectrometry: Identifies all proteins captured by the antibody

Standardized Reporting Format:

  • KD values should be reported with standard deviation from multiple measurements

  • Cross-reactivity should be quantified as percentage of signal compared to target protein

  • Concentration-dependent response curves should be included in validation reports

Reference Standards:

  • Include well-characterized reference antibodies when possible

  • Use recombinant YAB3 protein standards of known concentration

  • Develop standard operating procedures for consistent assessment

Comprehensive quantitative assessment not only ensures research reliability but also facilitates comparison between different antibody lots and sources.

What controls are essential when using YAB3 antibodies for different experimental applications?

Appropriate controls are critical for interpreting results obtained with YAB3 antibodies. Essential controls vary by application:

Western Blot Controls:

  • Positive control: Recombinant YAB3 protein with tag

  • Negative control: Extract from yab3 knockout/knockdown plant

  • Loading control: Housekeeping protein unaffected by experimental conditions

  • Peptide competition: Antibody pre-incubated with immunizing peptide

Immunohistochemistry/Immunofluorescence Controls:

  • Technical controls: Secondary antibody only, isotype control

  • Biological controls: Tissues known to express or lack YAB3

  • Specificity control: Pre-absorption with antigen

  • Counterstains: Nuclear marker to establish subcellular localization

ChIP Controls:

  • Input control: Sheared chromatin before immunoprecipitation

  • IgG control: Non-specific IgG matching antibody host species

  • Positive locus: Known YAB3 binding site

  • Negative locus: Region not bound by YAB3

  • Biological control: yab3 mutant tissue

Immunoprecipitation Controls:

  • Pre-immune serum control

  • IgG control matching antibody host species

  • Reverse co-IP when studying protein interactions

  • Input sample (typically 5-10% of starting material)

Systematic inclusion of these controls enables confident interpretation of results and troubleshooting of unexpected outcomes.

How can YAB3 antibodies be used to study developmental changes in plant organ polarity?

YAB3 antibodies offer powerful tools for investigating the temporal and spatial dynamics of organ polarity establishment in plants:

Developmental Time-Course Analysis:

  • Immunohistochemistry at defined developmental stages reveals the spatiotemporal pattern of YAB3 accumulation

  • Western blot quantification across developmental stages can correlate YAB3 expression with specific morphological changes

  • Integration with in situ hybridization can distinguish between transcriptional and post-transcriptional regulation

Cell-Type Specific Localization:

  • Immunofluorescence microscopy with cell-wall or organelle markers allows precise cellular and subcellular localization

  • Super-resolution microscopy can reveal fine-scale distribution patterns within cells

  • Combining with laser capture microdissection enables cell-type specific proteomic analysis

Protein Dynamics During Development:

  • Antibody-based fluorescence recovery after photobleaching (FRAP) using labeled antibody fragments

  • Pulse-chase immunoprecipitation to track protein turnover rates

  • Combining with inducible systems to track newly synthesized YAB3 localization

Protein Modifications During Development:

  • Phospho-specific YAB3 antibodies can track activation states

  • Combined with mass spectrometry to identify developmental stage-specific modifications

  • ChIP-seq at different developmental stages to track binding site dynamics

This multi-faceted approach can reveal how YAB3 protein accumulation, localization, modification, and activity change during critical developmental transitions in plant organ formation.

What considerations are important when designing multiplexed immunofluorescence experiments with YAB3 antibodies?

Multiplexed immunofluorescence enables simultaneous visualization of YAB3 alongside other proteins or cellular structures, providing valuable contextual information. Key considerations include:

Antibody Compatibility:

  • Host species selection: Choose antibodies raised in different host species to allow simultaneous detection

  • Isotype selection: When using multiple antibodies from the same host, select different isotypes for specific secondary detection

  • Validation: Test each antibody individually before multiplexing to confirm specificity

Fluorophore Selection:

  • Spectral separation: Choose fluorophores with minimal spectral overlap

  • Signal strength balancing: Match fluorophore brightness to relative abundance of target proteins

  • Photobleaching characteristics: Consider differential photobleaching rates for quantitative applications

Sample Preparation Optimization:

  • Fixation method: Optimize to preserve all target epitopes

  • Antigen retrieval: Different proteins may require different retrieval methods

  • Blocking strategy: Must be effective for all antibodies in the multiplex panel

Detection Order Strategy:

  • Sequential detection: Apply and detect antibodies sequentially when cross-reactivity is a concern

  • Simultaneous incubation: Reduces processing time but requires thorough validation

  • Signal amplification: Consider selective amplification for low-abundance targets

Controls for Multiplexed Experiments:

  • Single-color controls to establish bleed-through parameters

  • Absorption controls where one primary antibody is omitted

  • Tissue controls with known expression patterns for each target

Careful optimization of these parameters enables robust multiplexed detection of YAB3 alongside other proteins of interest, providing valuable insights into its functional context in plant development.

How can database resources be leveraged to improve YAB3 antibody selection and experimental design?

Strategic use of database resources can significantly enhance YAB3 antibody research from selection through experimental design:

Antibody Database Integration:

  • The Antibody Society's YAbS database provides detailed information on antibody development timelines, formats, and applications

  • These resources can inform selection of optimal antibody formats for specific applications

  • Validation data in these databases can guide experimental design decisions

Sequence Database Utilization:

  • Compare YAB3 sequences across species to identify conserved epitopes

  • Predict potential post-translational modifications that might affect antibody recognition

  • Design species-specific or cross-reactive antibodies based on sequence conservation analysis

Structural Database Applications:

  • Use protein structure databases to identify surface-exposed regions suitable as epitopes

  • Apply homology modeling techniques when crystallographic data is unavailable

  • Integrate with computational antibody design tools to enhance specificity

Expression Database Integration:

  • Utilize transcriptomic databases to identify tissues with highest YAB3 expression

  • Plan experiments targeting developmental stages with dynamic YAB3 expression

  • Design appropriate controls based on tissues with known expression levels

Methodological Repository Insights:

  • Access protocols optimized for plant transcription factor antibodies

  • Implement standardized validation procedures for reproducibility

  • Contribute validation data to community resources to advance the field

The strategic integration of these database resources throughout the research workflow enhances experimental design efficiency and improves the reliability of results obtained with YAB3 antibodies.

How might emerging antibody technologies impact future YAB3 research?

The rapidly evolving landscape of antibody technologies offers exciting opportunities for advancing YAB3 research:

Nanobodies and Single-Domain Antibodies:

  • Smaller size enables access to sterically hindered epitopes

  • Superior tissue penetration for whole-mount immunohistochemistry

  • Potential for intracellular expression as "intrabodies" to track YAB3 in living cells

CRISPR-Based Epitope Tagging:

  • Endogenous tagging of YAB3 enables use of highly validated tag-specific antibodies

  • Preserves native expression patterns and regulatory mechanisms

  • Reduces reliance on species-specific antibodies for cross-species research

Synthetic Antibody Libraries:

  • Phage or yeast display technologies enable rapid development of high-affinity binders

  • Selection under defined conditions can yield application-specific antibodies

  • Reduces dependence on animal immunization

Antibody-Oligonucleotide Conjugates:

  • DNA-barcoded antibodies enable highly multiplexed protein detection

  • Spatial transcriptomics integration links YAB3 protein localization with gene expression

  • Single-cell resolution of protein-protein interactions through proximity ligation

Computational Antibody Engineering:

  • Machine learning approaches predict optimal antibody sequences

  • Molecular dynamics simulations enhance affinity and specificity

  • Rational design of conformation-specific antibodies for functional states of YAB3

These emerging technologies promise to overcome current limitations in studying plant transcription factors like YAB3, enabling more precise spatial, temporal, and quantitative analyses of their functions in plant development.

What standards should be established for rigorous validation of YAB3 antibodies in the research community?

Establishing community standards for antibody validation would significantly enhance research reproducibility. For YAB3 antibodies, comprehensive validation standards should include:

Minimum Validation Requirements:

  • Genetic validation using knockout/knockdown controls

  • Independent detection methods (western blot, immunoprecipitation, immunohistochemistry)

  • Epitope mapping to define the recognized region

  • Cross-reactivity profiling against other YABBY family members

  • Species cross-reactivity assessment for comparative studies

Quantitative Performance Metrics:

  • Sensitivity: Limit of detection (LOD) and limit of quantification (LOQ)

  • Specificity: Signal-to-noise ratio in relevant applications

  • Reproducibility: Intra- and inter-lot variation assessments

  • Affinity: KD values determined by SPR or similar technologies

Application-Specific Validation:

  • ChIP-grade validation including immunoprecipitation efficiency

  • Immunohistochemistry validation including fixation compatibility

  • Flow cytometry validation if applicable

Standardized Reporting Format:

  • Comprehensive antibody validation reports with all raw data

  • Experimental conditions fully detailed for reproducibility

  • Specific recommendations for optimal use conditions

Data Deposition in Public Repositories:

  • Submission of validation data to antibody validation databases

  • Integration with plant-specific resources

  • Association with publications using these antibodies

Community adoption of these standards would enhance confidence in research findings and accelerate progress in understanding YAB3 function across plant species.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.